A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Clinical trial NCT06929624 · RECRUITING
Trial details
- NCT number
- NCT06929624
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-24
- Primary completion
- 2027-03-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.